Neurotoxicity of ϐ-amyloid peptide (Aϐ) in Alzheimer's disease (AD) is usually thought to arise from the nonspecific effects of high concentrations of Aϐ on vulnerable neurons, resulting in membrane destabilization and increasing intracellular calcium concentration. This review advances the hypothesis that at early stages of AD, when Aϐ is present in lower amounts, its ability to perturb the function of cellular targets is mediated by specific cofactors present on the cell surface and intracellularly. Receptor for advanced glycation endproducts (RAGE) is a cell-surface receptor which binds Aϐ and amplifies its effects on cells in the nanomolar range. The intracellular enzyme Aϐ-binding alcohol dehydrogenase (ABAD) is likely to engage nascent Aϐ formed in the endoplasmic reticulum, and to mediate cell stress from this site. The analysis of Aϐ interaction with RAGE and ABAD, as well as other cofactors, provides insight into new mechanisms and, potentially, identifies therapeutic targets relevant to neuronal dysfunction in AD.
Skip Nav Destination
Conference Article| February 01 2001
Alzheimer's disease: inside, outside, upside down
Shi Du Yan ;
Ann M. Schmidt ;
Biochem Soc Symp (2001) 67: 15–22.
- Views Icon Views
- Share Icon Share
Cora O'Neill, Brian Anderton, Shi Du Yan, Ann M. Schmidt, David Stern; Alzheimer's disease: inside, outside, upside down. Biochem Soc Symp 1 February 2001; 67 15–22. doi: https://doi.org/10.1042/bss0670015
Download citation file:
Don't already have an account? Register
Get Access To This Article
Buy This Article